SCHEMBL11922016

SCHEMBL11922016

Cn1c2ccccc2c2ccc(N(c3ccccc3)c3cccc(N(c4ccccc4)c4ccc5c6ccccc6n(C)c5c4)c3)cc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.52
KIF11 P52732 1/20 0.47
HPGD P15428 6/20 0.47
KDM4E B2RXH2 5/20 0.47
ALDH1A1 P00352 3/20 0.47
HSD17B10 Q99714 3/20 0.47
MAPT P10636 5/20 0.44
LMNA P02545 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
PABPC1 P11940 1/20 0.44
ATM Q13315 1/20 0.43
RXRA P19793 1/20 0.43
RXRB P28702 1/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
HTT P42858 1/20 0.41
ALKBH5 Q6P6C2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11922000 0.97 GPR3 (0.52) GPR3KIF11HPGDKDM4EALDH1A1
SCHEMBL15747046 0.97 GPR3 (0.55) GPR3KIF11HPGDKDM4EALDH1A1
SCHEMBL11922031 0.92 GPR3 (0.47) GPR3KIF11HPGDKDM4EALDH1A1
SCHEMBL11922020 0.92 RXRA (0.51) GPR3KIF11HPGDKDM4EALDH1A1
SCHEMBL11922017 0.92 RXRA (0.51) GPR3KIF11HPGDKDM4EALDH1A1
SCHEMBL17904090 0.92 GPR3 (0.45) GPR3KIF11HPGDKDM4EALDH1A1
SCHEMBL18564880 0.91 RXRA (0.48) GPR3KIF11HPGDKDM4EALDH1A1
SCHEMBL11922045 0.91 GPR3 (0.46) GPR3KIF11HPGDKDM4EALDH1A1
SCHEMBL21919228 0.91 GPR3 (0.48) GPR3KIF11HPGDKDM4EALDH1A1
SCHEMBL18564813 0.91 RXRA (0.50) GPR3KIF11HPGDKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9650565-B2 Carbazole compound and use thereof TOSOH CORPORATION (JP) 2017-05-16 US disclosed
US-9650565-B2 Carbazole compound and use thereof TOSOH CORPORATION (JP) 2017-05-16 US disclosed
US-20170117486-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-04-27 US disclosed
US-20170117486-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-04-27 US disclosed
US-20120203010-A1 CARBAZOLE COMPOUND AND USE THEREOF TOSOH CORPORATION (JP) 2012-08-09 US disclosed
US-20120203010-A1 CARBAZOLE COMPOUND AND USE THEREOF TOSOH CORPORATION (JP) 2012-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120203010-A1 CARBAZOLE COMPOUND AND USE THEREOF AR, DRD3, AHR GPR3 17/4885KIF11 4048/4885HPGD 4002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.